We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$51.6B
AUM Growth
+$5.68B
Cap. Flow
-$429M
Cap. Flow %
-0.83%
Top 10 Hldgs %
17.19%
Holding
3,020
New
40
Increased
1,307
Reduced
1,586
Closed
73

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$73.8M
2
AMZN icon
Amazon
AMZN
+$68.6M
3
AAPL icon
Apple
AAPL
+$64.9M
4
MSFT icon
Microsoft
MSFT
+$61.4M
5
META icon
Meta Platforms (Facebook)
META
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 15.13%
3 Healthcare 13.65%
4 Consumer Discretionary 10.39%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIO icon
2901
Mustang Bio
MBIO
$4.5M
$66K ﹤0.01%
26
FENC icon
2902
Fennec Pharmaceuticals
FENC
$369M
$65K ﹤0.01%
13,375
-280
-2% -$1.84K
KODK icon
2903
Kodak
KODK
$946M
$65K ﹤0.01%
22,106
-390
-2% -$1.19K
TLGT
2904
DELISTED
Teligent, Inc
TLGT
$63K ﹤0.01%
5,434
-105
-2% -$1.58K
CTIC
2905
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$63K ﹤0.01%
64,749
-1,330
-2% -$1.4K
AMPE
2906
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$62K ﹤0.01%
366
-7
-2% -$1.2K
IBRX icon
2907
ImmunityBio
IBRX
$7.69B
$60K ﹤0.01%
38,052
-190
-0.5% -$239
KEG
2908
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$59K ﹤0.01%
14,548
-250
-2% -$723
MARK
2909
DELISTED
Remark Holdings, Inc.
MARK
$57K ﹤0.01%
3,098
-68
-2% -$1.38K
SER icon
2910
Serina Therapeutics
SER
$33M
$55K ﹤0.01%
386
+22
+6% +$3.22K
KA
2911
DELISTED
Kineta, Inc. Common Stock
KA
$55K ﹤0.01%
315
+55
+21% +$26.9K
IMH
2912
DELISTED
Impac Mortgage Holdings Inc.
IMH
$55K ﹤0.01%
13,931
-110
-0.8% -$437
RMNI icon
2913
Rimini Street
RMNI
$445M
$54K ﹤0.01%
10,900
-235
-2% -$1.27K
SURF
2914
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$54K ﹤0.01%
+11,297
New +$55.6K
BRS
2915
DELISTED
Bristow Group, Inc.
BRS
$53K ﹤0.01%
47,839
-52,241
-52% -$114K
QHC
2916
DELISTED
Quorum Health Corporation
QHC
$52K ﹤0.01%
36,856
-23,915
-39% -$64.4K
AEG icon
2917
Aegon
AEG
$14B
$50K ﹤0.01%
12,232
-5,623
-31% -$24.6K
CLSD
2918
DELISTED
Clearside Biomedical
CLSD
$50K ﹤0.01%
2,421
-44
-2% -$873
PFIE
2919
DELISTED
Profire Energy, Inc
PFIE
$49K ﹤0.01%
27,135
-620
-2% -$1.1K
ZN
2920
DELISTED
Zion Oil & Gas, Inc.
ZN
$49K ﹤0.01%
65,077
-1,405
-2% -$773
NL icon
2921
NLI Holdings
NL
$283M
$46K ﹤0.01%
11,930
-40
-0.3% -$163
SNNA
2922
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$46K ﹤0.01%
19,794
+417
+2% +$1.13K
LYG icon
2923
Lloyds Banking Group
LYG
$90.9B
$44K ﹤0.01%
13,707
-4,650
-25% -$14.2K
NMTR
2924
DELISTED
9 Meters Biopharma
NMTR
$44K ﹤0.01%
1,149
-20
-2% -$865
AMR
2925
DELISTED
Alta Mesa Resources Inc
AMR
$39K ﹤0.01%
146,760
-620
-0.4% -$469

Similar funds

RhumbLine Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, RhumbLine Advisers held 3,020 positions worth $51.6B, up 12% from $46B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.7%. RhumbLine Advisers opened 40 new positions and exited 73, leaving the 3,020-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2019 buy was Fox Class A: 602,636 shares worth $22.1M.
  • RhumbLine Advisers added most to Walt Disney in Q1 2019, an estimated $73.8M increase.
  • RhumbLine Advisers's biggest Q1 2019 reduction was Wells Fargo, cutting an estimated $16.4M.
  • RhumbLine Advisers fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $89.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $51.6B portfolio in Q1 2019.
  • RhumbLine Advisers opened 40 new positions and closed 73 in Q1 2019.
  • RhumbLine Advisers's portfolio value rose 12% quarter-over-quarter to $51.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.